-
41
PIVKA-II as a surrogate biomarker for therapeutic response in Non-AFP-secreting hepatocellular carcinoma
Published 2025-02-01Subjects: Get full text
Article -
42
GGCT participates in the malignant process of hepatocellular cancer cells by regulating the PTEN/PI3K/AKT pathway through binding to EZH2
Published 2025-02-01Subjects: Get full text
Article -
43
Donafenib combined with sintilimab for advanced hepatocellular carcinoma: a single arm phase II trial
Published 2025-02-01Subjects: “…Hepatocellular carcinoma…”
Get full text
Article -
44
Risk of progression and the cause of mortality at chronic viral mixed-hepatitis
Published 2013-07-01Subjects: Get full text
Article -
45
-
46
Helicobacter pylori Infection and Hepatobiliary Pathology
Published 2018-09-01Subjects: Get full text
Article -
47
Resolved Hepatitis B: Achieved or Imaginary Wellbeing?
Published 2021-04-01Subjects: Get full text
Article -
48
-
49
Chronic alcohol intoxication and liver diseases
Published 2009-02-01Subjects: “…alcohol-associated hepatocellular carcinoma…”
Get full text
Article -
50
Risk Factors of Portal Vein Thrombosis in Patients with Different Child-Pugh Classes Liver Cirrhosis
Published 2023-08-01Subjects: Get full text
Article -
51
-
52
-
53
The Combination of D-TACE-HAIC, Lenvatinib, and PD-1 Inhibitors Shows Significant Clinical Efficacy in Patients with Unresectable Hepatocellular Carcinoma
Published 2025-02-01Subjects: “…unresectable hepatocellular carcinomas…”
Get full text
Article